ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.350
0.00 (0.00%)
At close: Jul 17, 2026, 4:00 PM EDT
1.370
+0.020 (1.48%)
After-hours: Jul 17, 2026, 7:26 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $171.71 million as of July 17, 2026. Its market cap has decreased by -49.66% in one year.
Market Cap
171.71M
Enterprise Value
376.96M
1-Year Change
-49.66%
Ranking
Category
Stock Price
$1.35
ChartMarket Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $171.71M, a decrease of -91.59%. That is a compound annual growth rate of -33.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 171.71M | -60.73% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organogenesis Holdings | 337.13M |
| Alpha Teknova | 290.59M |
| SIGA Technologies | 246.73M |
| Anika Therapeutics | 202.91M |
| Journey Medical | 197.15M |
| Lifecore Biomedical | 175.54M |
| Aurora Cannabis | 163.59M |
| Cardiol Therapeutics | 139.05M |